Researchers uncover how T and B cells learn to attack liver cells in metabolic diseases
August 19, 2022 -- Weill Cornell Medicine researchers have identified a protein that is instrumental in activating both T and B cells to attack liver cells in metabolic disorders, helping to further understanding of the dynamics underlying liver damage that can accompany type 2 diabetes and obesity. Read More
Key vulnerability discovered across all major SARS-CoV-2 variants
August 18, 2022 -- Researchers at the University of British Columbia have discovered a “weak spot” across all major variants of the SARS-CoV-2 virus, including the recently emerged BA.1 and BA.2 omicron subvariants, using cryo-electron microscopy to reveal the atomic-level structure of the vulnerability on the spike protein. Read More
Scientists capture first image of antigen-bound T-cell receptor at atomic resolution
August 18, 2022 -- Using cryo-electron microscopy, scientists from Goethe University Frankfurt (in collaboration with the University of Oxford and the Max Planck Institute of Biophysics) have for the first time been able to visualize the whole T-cell receptor complex with bound antigen at atomic resolution. Read More
Researchers use human serum to detect gut microbes that activate immune cells
August 18, 2022 -- Using human serum, investigators at Cedars-Sinai Medical Center and the National Institute of Allergy and Infectious Diseases have devised a new method that allows the identification of gut microbes that activate immunity after breaching the gut barrier. Read More
Research furthers understanding of how cellular waste supercharges immune system
August 17, 2022 -- Van Andel Institute researchers have discovered that immune cells are much more flexible than previously thought in selecting the nutrients that fuel their function, including what was previously considered cellular waste. Read More
Cancer vaccine eliminates tumors, prevents recurrence in mice with metastatic melanoma
August 16, 2022 -- Tufts University School of Engineering researchers have come up with a method of targeting cancer in mice using an mRNA-based vaccine that is delivered directly into the lymphatic system, eliminating tumors and preventing their recurrence. Read More
New antibody neutralizes all known SARS-CoV-2 variants: study
August 12, 2022 -- An antibody developed at Boston Children’s Hospital neutralizes all known SARS-CoV-2 variants, including omicron subvariants, which may inform the design of future COVID-19 vaccines. Read More
Bio-Rad extends range of StarBright Violet, UltraViolet dyes for multiplex flow cytometry
August 12, 2022 -- Bio-Rad Laboratories has extended its range of StarBright dyes to provide greater flexibility in multicolor flow cytometry panels for immunology research. Read More
‘Jumping gene’ affects immune system response, helps mice survive virus infections
August 11, 2022 -- Australian researchers have learned a particular transposable element, a “jumping gene,” has a profound effect on the immune response to virus infection, at least in mice. Read More
Antibodies create broad SARS immune response: study
August 11, 2022 -- Scientists from Scripps Research have discovered certain antibodies are capable of immunity against many different SARS-CoV-2 variants, as well as other SARS viruses like SARS-CoV-1. Read More
Conferences
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
